Biomarker Panel Could Provide Simpler Type-I Diabetes Detection, Genalyte Inc. Reveals

According to Juvenile Diabetes Research Foundation, an estimated 3 million Americans are living with type-1 diabetes (T1D), and as many as 80 people are diagnosed with diabetes in the US every day. Current assays employed in the detection of type-1 diabetes are expensive and time consuming, which is why Genalyte‘s new biomarker panel could be a much needed update to the detection process, utilizing Micro Ring sensors constructed using silicon photonic technology.

Hey, check out all the engineering jobs. Post your resume today!